These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 25867436)
1. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk. Zhou CX; Zhao JH Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436 [TBL] [Abstract][Full Text] [Related]
2. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies. Qian T; Zhang B; Qian C; He Y; Li Y Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298 [TBL] [Abstract][Full Text] [Related]
3. Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis. Xu Z; Ma W; Gao L; Xing B Tumour Biol; 2014 Apr; 35(4):3211-21. PubMed ID: 24254311 [TBL] [Abstract][Full Text] [Related]
4. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis. Xin Y; Hao S; Lu J; Wang Q; Zhang L PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305 [TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors. Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164 [TBL] [Abstract][Full Text] [Related]
6. Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis. Jia TL; Wu HJ; Wang HB; Ma WB; Xing B Genet Mol Res; 2015 Oct; 14(4):12577-84. PubMed ID: 26505408 [TBL] [Abstract][Full Text] [Related]
7. Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma. Cui QK; Zhu JX; Liu WD; Wang YH; Wang ZG Pak J Med Sci; 2014; 30(6):1409-14. PubMed ID: 25674148 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy. Mo J; Luo M; Cui J; Zhou S Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845 [TBL] [Abstract][Full Text] [Related]
9. Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer. He MG; Zheng K; Tan D; Wang ZX Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051038 [TBL] [Abstract][Full Text] [Related]
10. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer. Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265 [TBL] [Abstract][Full Text] [Related]
11. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer. Zhao F; Shang Y; Zeng C; Gao D; Li K Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894 [TBL] [Abstract][Full Text] [Related]
12. Association of ERCC1 and ERCC2 Gene Polymorphisms with Pancreatic Cancer Risk: A Meta-Analysis. Xie F; Sun Q; Zhang E; Mu Y Crit Rev Eukaryot Gene Expr; 2020; 30(3):231-237. PubMed ID: 32749109 [TBL] [Abstract][Full Text] [Related]
13. Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk. Hui L; Yue S; Gao G; Chang H; Li X Tumour Biol; 2014 Aug; 35(8):7451-7. PubMed ID: 24782032 [TBL] [Abstract][Full Text] [Related]
14. Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population. Xiao S; Gao L; Liu Y; Yu T; Jin C; Pan L; Zhu G; Lu X Mutat Res; 2013 Feb; 751(1):52-8. PubMed ID: 23147699 [TBL] [Abstract][Full Text] [Related]
15. Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population. Zhao R; Ying MF Genet Mol Res; 2016 Mar; 15(1):15017263. PubMed ID: 26985954 [TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis. Zhang H; Ge J; Hong H; Bi L; Sun Z World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903 [TBL] [Abstract][Full Text] [Related]
17. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis. Zhao H; Wang LE; Li D; Chamberlain RM; Sturgis EM; Wei Q Carcinogenesis; 2008 Aug; 29(8):1560-6. PubMed ID: 18635523 [TBL] [Abstract][Full Text] [Related]
18. ERCC1 and ERCC2 variants predict survival in gastric cancer patients. Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723 [TBL] [Abstract][Full Text] [Related]
19. Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population. Ni M; Zhang WZ; Qiu JR; Liu F; Li M; Zhang YJ; Liu Q; Bai J Sci Rep; 2014 Feb; 4():4112. PubMed ID: 24531312 [TBL] [Abstract][Full Text] [Related]
20. ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes. Lu X; Liu Y; Yu T; Xiao S; Bao X; Pan L; Zhu G; Cai Y; Liu Q; Jin C; Yang J; Wu S; An L; van der Straaten T PLoS One; 2013; 8(4):e60006. PubMed ID: 23593158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]